JP2020502040A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502040A5 JP2020502040A5 JP2019516149A JP2019516149A JP2020502040A5 JP 2020502040 A5 JP2020502040 A5 JP 2020502040A5 JP 2019516149 A JP2019516149 A JP 2019516149A JP 2019516149 A JP2019516149 A JP 2019516149A JP 2020502040 A5 JP2020502040 A5 JP 2020502040A5
- Authority
- JP
- Japan
- Prior art keywords
- disorders
- cannabinoid
- medium
- symptoms
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000024891 symptom Diseases 0.000 claims 15
- 238000000034 method Methods 0.000 claims 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 13
- 208000035475 disorder Diseases 0.000 claims 13
- 238000000605 extraction Methods 0.000 claims 13
- 229930003827 cannabinoid Natural products 0.000 claims 12
- 239000003557 cannabinoid Substances 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 10
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims 8
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 8
- 229950011318 cannabidiol Drugs 0.000 claims 8
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims 8
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims 8
- 239000004094 surface-active agent Substances 0.000 claims 8
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 239000003921 oil Substances 0.000 claims 6
- 235000019198 oils Nutrition 0.000 claims 6
- 239000002028 Biomass Substances 0.000 claims 5
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 claims 4
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims 4
- 229960004242 dronabinol Drugs 0.000 claims 4
- 239000000194 fatty acid Substances 0.000 claims 4
- 229930195729 fatty acid Natural products 0.000 claims 4
- 239000002002 slurry Substances 0.000 claims 4
- 229940065144 cannabinoids Drugs 0.000 claims 3
- 150000004665 fatty acids Chemical class 0.000 claims 3
- 150000003904 phospholipids Chemical class 0.000 claims 3
- 206010010904 Convulsion Diseases 0.000 claims 2
- -1 D-lymonene Substances 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 238000002156 mixing Methods 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims 2
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 208000031104 Arterial Occlusive disease Diseases 0.000 claims 1
- 200000000007 Arterial disease Diseases 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 241000070918 Cima Species 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 101000656751 Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) 30S ribosomal protein S24e Proteins 0.000 claims 1
- 206010028813 Nausea Diseases 0.000 claims 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 claims 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims 1
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 229920001213 Polysorbate 20 Polymers 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 206010047700 Vomiting Diseases 0.000 claims 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 229910052586 apatite Inorganic materials 0.000 claims 1
- 208000021328 arterial occlusion Diseases 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 230000008468 bone growth Effects 0.000 claims 1
- 239000004359 castor oil Substances 0.000 claims 1
- 235000019438 castor oil Nutrition 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000036461 convulsion Effects 0.000 claims 1
- 239000006184 cosolvent Substances 0.000 claims 1
- 230000006866 deterioration Effects 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 125000005456 glyceride group Chemical group 0.000 claims 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000000265 homogenisation Methods 0.000 claims 1
- 229930195733 hydrocarbon Natural products 0.000 claims 1
- 150000002430 hydrocarbons Chemical class 0.000 claims 1
- 230000001506 immunosuppresive effect Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 1
- 239000002480 mineral oil Substances 0.000 claims 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims 1
- 230000008693 nausea Effects 0.000 claims 1
- 210000000653 nervous system Anatomy 0.000 claims 1
- 239000002417 nutraceutical Substances 0.000 claims 1
- 235000021436 nutraceutical agent Nutrition 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- 125000006353 oxyethylene group Chemical group 0.000 claims 1
- 239000012188 paraffin wax Substances 0.000 claims 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 claims 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 claims 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 claims 1
- 229920001451 polypropylene glycol Polymers 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 229940032094 squalane Drugs 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 1
- 239000008158 vegetable oil Substances 0.000 claims 1
- 239000000341 volatile oil Substances 0.000 claims 1
- 230000008673 vomiting Effects 0.000 claims 1
- 239000001993 wax Substances 0.000 claims 1
- 239000000811 xylitol Substances 0.000 claims 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 1
- 229960002675 xylitol Drugs 0.000 claims 1
- 235000010447 xylitol Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL248150 | 2016-09-29 | ||
| IL248150A IL248150B (en) | 2016-09-29 | 2016-09-29 | Method for selective extraction of cannabinoids from a plant source |
| PCT/IL2017/051099 WO2018061009A1 (en) | 2016-09-29 | 2017-09-28 | Method for selective extraction of cannabinoids from a plant source |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020502040A JP2020502040A (ja) | 2020-01-23 |
| JP2020502040A5 true JP2020502040A5 (https=) | 2020-11-12 |
| JP7265264B2 JP7265264B2 (ja) | 2023-04-26 |
Family
ID=57907553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019516149A Active JP7265264B2 (ja) | 2016-09-29 | 2017-09-28 | 植物源からカンナビノイドを選択的に抽出する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11666618B2 (https=) |
| EP (1) | EP3518950B1 (https=) |
| JP (1) | JP7265264B2 (https=) |
| KR (1) | KR102569534B1 (https=) |
| CN (1) | CN109996551A (https=) |
| AU (1) | AU2017335724B2 (https=) |
| BR (1) | BR112019006081B1 (https=) |
| CA (1) | CA3038474A1 (https=) |
| ES (1) | ES3056133T3 (https=) |
| IL (1) | IL248150B (https=) |
| MX (1) | MX2019003736A (https=) |
| NZ (1) | NZ752820A (https=) |
| WO (1) | WO2018061009A1 (https=) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX380274B (es) | 2011-06-30 | 2025-03-12 | Gallo Winery E & J | Colorante cristalino natural y proceso para producción. |
| US11226155B2 (en) | 2013-03-15 | 2022-01-18 | E. & J. Gallo Winery | Multi-chamber dryer using adjustable conditioned air flow |
| IL248150B (en) | 2016-09-29 | 2018-05-31 | Garti Nissim | Method for selective extraction of cannabinoids from a plant source |
| IL248148B (en) * | 2016-09-29 | 2021-09-30 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | A method for extracting a compound from plant origin |
| IL248149B (en) | 2016-09-29 | 2020-03-31 | Garti Nissim | Dilutable formulations of cannbinoids and processes for their preparation |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| CA3089994A1 (en) | 2018-01-31 | 2019-08-08 | Canopy Holdings, LLC | Hemp powder |
| WO2019153073A1 (en) | 2018-02-07 | 2019-08-15 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof |
| GB201806953D0 (en) * | 2018-04-27 | 2018-06-13 | Gw Res Ltd | Cannabidiol Preparations |
| WO2019207554A1 (en) * | 2018-04-27 | 2019-10-31 | Radient Technologies Inc. | Extraction of compounds from cannabis biomass using food-grade solvent |
| CA3054203C (en) | 2018-05-03 | 2021-01-05 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof |
| US10897925B2 (en) | 2018-07-27 | 2021-01-26 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
| EP3833369A4 (en) | 2018-08-08 | 2022-05-04 | Neptune Wellness Solutions Inc. | PROCESS FOR COLD EXTRACTION OF CANNABINOIDS AND TERPENES FROM CANNABIS BY ORGANIC SOLVENTS |
| WO2020077153A1 (en) | 2018-10-10 | 2020-04-16 | Canopy Holdings, LLC | Synthesis of cannabigerol |
| WO2020086291A1 (en) | 2018-10-22 | 2020-04-30 | Jones Lisa Marie | Topical compositions incorporating cannabis |
| US11221179B2 (en) | 2018-10-26 | 2022-01-11 | E. & J. Gallo Winery | Low profile design air tunnel system and method for providing uniform air flow in a refractance window dryer |
| CN113727768B (zh) * | 2018-11-27 | 2023-05-12 | 阿维尼翁大学 | 提取感兴趣的物质的方法 |
| BR112021011388A2 (pt) * | 2018-12-11 | 2021-08-31 | Naturalia Ingredients S.R.L. | Método de extração e composição obtida pelo mesmo |
| WO2020176806A1 (en) * | 2019-02-27 | 2020-09-03 | 3-Delta, Inc. | Compositions that contain lipophilic plant material and surfactant, and related methods |
| US10993928B2 (en) | 2019-04-26 | 2021-05-04 | Natural Extraction Systems, LLC | Compositions comprising non-crystalline forms of cannabidiol |
| EP3983367B1 (en) | 2019-06-11 | 2025-07-30 | Symrise AG | Synthesis and purification of cannabigerol and its application |
| CN110200953B (zh) * | 2019-06-15 | 2022-02-08 | 汉义生物科技（北京）有限公司 | 大麻素在制备吸入给药药物中的应用 |
| US12036485B1 (en) * | 2019-07-16 | 2024-07-16 | Green Vault Systems, LLC | Continuous flow cold water extraction |
| US12226390B2 (en) | 2019-07-21 | 2025-02-18 | Scf Pharma Inc. | Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof |
| AU2020326738A1 (en) * | 2019-08-08 | 2022-03-03 | Purcann Pharma Inc. | Oral formulations of cannabis extracts and methods of making same |
| PE20221403A1 (es) * | 2019-08-27 | 2022-09-15 | Herbolea Biotech S P A | Concentrado y aislado de cannabinoide, metodo para su obtencion y uso |
| WO2021076159A1 (en) * | 2019-10-14 | 2021-04-22 | Capna Ip Capital, Llc | Improved methods to reduce chlorophyll co-extraction through extraction of select moieties essential oils and aromatic isolates |
| US10941131B1 (en) * | 2019-10-28 | 2021-03-09 | Pure Tonic Concentrates, LLC | Conversion of cannabidiol or delta-9 tetrahydrocannabinolic acid to delta-9 tetrahydrocannabinol and delta-8 tetrahydrocannabinol in nontoxic heterogeneous mixtures |
| GB201916846D0 (en) * | 2019-11-19 | 2020-01-01 | Gw Res Ltd | Cannabidiol-type cannabinoid compound |
| WO2021113083A1 (en) | 2019-12-06 | 2021-06-10 | JLABS Beauty LLC | Topical compositions containing rose oil and cannabidiol and methods of making and using the same |
| US11291699B1 (en) | 2019-12-13 | 2022-04-05 | Delmarva Hemp, LLC | Method for solvent-free extraction and concentration of full spectrum of cannabinoids in a carrier oil |
| EP4093417A4 (en) * | 2020-01-24 | 2024-03-27 | E. & J. Gallo Winery | Systems and methods for processing and stabilizing plant materials |
| US10919828B1 (en) * | 2020-02-14 | 2021-02-16 | Aicardo Roa-Espinosa | Process for manufacturing cannabidiol |
| GB202002754D0 (en) | 2020-02-27 | 2020-04-15 | Gw Res Ltd | Methods of treating tuberous sclerosis complex with cannabidiol and everolimus |
| MX2022013533A (es) | 2020-04-30 | 2022-11-16 | Hydro Dynamics Inc | Sistema y metodo para el tratamiento de plantas para la sintesis de compuestos de las mismas. |
| PL244803B1 (pl) * | 2020-05-18 | 2024-03-04 | Del Vis Spolka Z Ograniczona Odpowiedzialnoscia | Filtr papierosowy z octanu celulozy oraz sposób wytwarzania tego filtra |
| CA3179442A1 (en) | 2020-05-22 | 2021-11-25 | Brian Warrington | Compositions for treating acne and dermatological conditions |
| US12264296B2 (en) | 2020-09-02 | 2025-04-01 | Michael V. Zumpano | Compositions that contain lipophilic plant material and surfactant, and related methods |
| AU2020481908A1 (en) * | 2020-12-16 | 2023-06-29 | TARK, Hye Ryun | Method for preparing vegetable oil emulsion using cannabidiol oil |
| IL308880A (en) | 2021-05-28 | 2024-01-01 | Ananda Scient Inc | Methods for the treatment of post-traumatic stress disorder and traumatic brain injury with cannabinoids |
| EP4362936A4 (en) * | 2021-07-01 | 2025-04-30 | Ananda Scientififc, Inc. | CANNABINOID PAIN TREATMENT METHODS |
| WO2023283277A1 (en) * | 2021-07-06 | 2023-01-12 | Apex Medical Device Design, Llc | Fermented uni-sourced nanoemulsion of nigella sativa or cannabis sativa for use in medical, cosmetic, and recreational indications with a method of its production and use |
| KR102461951B1 (ko) | 2021-09-23 | 2022-11-03 | 재단법인춘천바이오산업진흥원 | 반응표면분석법을 활용한 대마 초임계 추출 최적화 |
| CN118119397A (zh) * | 2021-10-11 | 2024-05-31 | 神经科技国际有限公司 | 用于治疗神经病症的组合物和方法 |
| US11911427B2 (en) | 2022-03-12 | 2024-02-27 | Wilhelm Rumpf | Extraction and infusion of active components from plant materials |
| EP4514339A1 (en) | 2022-04-27 | 2025-03-05 | Jazz Pharmaceuticals Research UK Limited | Treatment of spasticity and pain in renally-impaired patients |
| EP4518971A4 (en) * | 2022-05-05 | 2026-04-29 | Ananda Scient Inc | SYSTEM AND METHOD FOR MANAGING RELATIONSHIPS, ORGANIZING, RETRIEVING AND SHARING DIFFERENT TYPES OF CONTENT |
| CA3266127A1 (en) * | 2022-08-30 | 2024-03-07 | Micellae Delivery Systems Inc. | Dilutable compositions and processes for extracting and refining sluggishly water-soluble polar oils from biomass |
| EP4626411A1 (en) | 2022-12-02 | 2025-10-08 | Jazz Pharmaceuticals Research UK Limited | Cannabinoids for treating essential tremor in patients |
| WO2025212856A1 (en) * | 2024-04-05 | 2025-10-09 | The Board Of Regents Of The University Of Texas System | Microemulsion formulations |
| WO2025229641A1 (en) | 2024-04-29 | 2025-11-06 | Ananda Scientific, Inc. | Methods for reducing nicotine and marijuana dependency by administration of cannabinoids |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1155698A4 (en) | 1999-01-29 | 2003-01-15 | Nitto Kasei Co Ltd | ORGANOBORAL COMPOUNDS HAVING COCCIDIOSTAT ACTIVITY |
| CH695661A5 (de) * | 2001-03-06 | 2006-07-31 | Forsch Hiscia Ver Fuer Krebsfo | Pharmazeutische Zusammensetzung. |
| IL165528A (en) | 2002-06-12 | 2010-11-30 | Yissum Res Dev Co | Liquid concentrates of self-assembled nano-sized structures and their use as carriers for active components |
| US7182950B2 (en) | 2002-06-12 | 2007-02-27 | Nutralease Ltd. | Nano-sized self-assembled liquid dilutable vehicles |
| EP1980564A1 (en) | 2002-12-18 | 2008-10-15 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
| EP1684776A1 (en) | 2003-07-25 | 2006-08-02 | Washington State University Research Foundation | Natural astaxanthin extract reduces dna oxidation |
| GB0504950D0 (en) * | 2005-03-10 | 2005-04-20 | Novartis Ag | Organic compositions |
| US20070104741A1 (en) * | 2005-11-07 | 2007-05-10 | Murty Pharmaceuticals, Inc. | Delivery of tetrahydrocannabinol |
| WO2008058366A1 (en) | 2006-09-28 | 2008-05-22 | Université de Montréal | Oil-in-water emulsions, methods of use thereof, methods of preparation thereof and kits thereof |
| CN106267902B (zh) | 2007-06-04 | 2019-08-20 | 高压生物科学公司 | 分子的压力提高的提取和分配 |
| IT1394400B1 (it) * | 2009-02-25 | 2012-06-15 | Neuroscienze Pharmaness S C Ar L | Composizioni farmaceutiche |
| JP5149837B2 (ja) | 2009-02-27 | 2013-02-20 | Ｊｘ日鉱日石エネルギー株式会社 | カロテノイドの製造方法 |
| CN102145084A (zh) | 2011-04-19 | 2011-08-10 | 宁夏医科大学 | 枸杞籽油自微乳化纳米组合物及其生产方法 |
| WO2013009928A1 (en) | 2011-07-11 | 2013-01-17 | Organic Medical Research | Cannabinoid formulations |
| CN103027863B (zh) | 2011-09-30 | 2015-02-25 | 伽蓝（集团）股份有限公司 | 一种含有牡丹提取物的微乳液及其制备方法和应用 |
| DK2804587T3 (da) | 2012-01-19 | 2019-08-12 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Formulering og fremgangsmåde til øgning af lægemidlers biotilgængelighed |
| WO2013165251A1 (en) | 2012-05-03 | 2013-11-07 | Echo Pharmaceuticals B.V. | Cannabis plant isolate comprising /\9-tetrahydrocannabinol and a method for preparing such an isolate |
| US20140056828A1 (en) | 2012-08-21 | 2014-02-27 | Indiran Pather | Novel formulations and uses for curcuma extracts |
| CH706963B1 (de) * | 2012-08-30 | 2016-03-31 | Ai Fame Gmbh | Verfahren zur Herstellung eines Cannabis enthaltenden Präparates. |
| CN103110582A (zh) | 2013-03-04 | 2013-05-22 | 上海医药工业研究院 | 大麻酚类化合物微乳剂及其制备方法 |
| WO2015011724A2 (en) | 2013-07-22 | 2015-01-29 | Kms Health Center Pvt Ltd | A novel omega -3 fatty acid composition with a plant extract |
| CN103690580B (zh) | 2013-11-07 | 2016-01-20 | 山西中医学院 | 穿心莲的微乳提取方法及其提取物 |
| WO2016004410A1 (en) | 2014-07-02 | 2016-01-07 | Cannavest Corp. | Novel process for generating hemp oil with a high cannabidiol (cbd) content |
| WO2016022936A1 (en) | 2014-08-07 | 2016-02-11 | Murty Pharmaceuticals, Inc. | An improved oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts |
| US11179333B2 (en) | 2014-08-29 | 2021-11-23 | Fuji Chemical Industries Co., Ltd. | Emulsion composition |
| US10016363B2 (en) | 2014-09-18 | 2018-07-10 | Virun, Inc. | Pre-spray emulsions and powders containing non-polar compounds |
| BR122021018502B1 (pt) | 2014-10-21 | 2022-05-03 | United Cannabis Corp | Formulação de canabinoide líquida |
| AU2016231788A1 (en) * | 2015-03-19 | 2017-10-12 | One World Cannabis Ltd | Preparations of cannabis emulsions and methods thereof |
| US10342747B2 (en) | 2015-12-16 | 2019-07-09 | PPP&C Inc. | Apparatus and method for preparing cosmeceutical ingredients containing epi-dermal delivery mechanisms |
| AU2017210319A1 (en) | 2016-01-20 | 2018-08-23 | Flurry Powders, Llc | Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation |
| CN105535111B (zh) * | 2016-02-16 | 2019-06-28 | 山西汉麻生物科技有限公司 | 一种富含大麻二酚的火麻浸膏及其制备方法 |
| CN105997985A (zh) | 2016-06-14 | 2016-10-12 | 云南瑞酚生物科技有限公司 | 一种大麻提取物在制备治疗痛风药物中的应用 |
| IL248150B (en) | 2016-09-29 | 2018-05-31 | Garti Nissim | Method for selective extraction of cannabinoids from a plant source |
| IL248148B (en) | 2016-09-29 | 2021-09-30 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | A method for extracting a compound from plant origin |
| IL248149B (en) | 2016-09-29 | 2020-03-31 | Garti Nissim | Dilutable formulations of cannbinoids and processes for their preparation |
-
2016
- 2016-09-29 IL IL248150A patent/IL248150B/en active IP Right Grant
-
2017
- 2017-09-28 EP EP17794792.6A patent/EP3518950B1/en active Active
- 2017-09-28 AU AU2017335724A patent/AU2017335724B2/en active Active
- 2017-09-28 KR KR1020197012346A patent/KR102569534B1/ko active Active
- 2017-09-28 CN CN201780073017.1A patent/CN109996551A/zh active Pending
- 2017-09-28 CA CA3038474A patent/CA3038474A1/en active Pending
- 2017-09-28 US US16/338,259 patent/US11666618B2/en active Active
- 2017-09-28 MX MX2019003736A patent/MX2019003736A/es unknown
- 2017-09-28 ES ES17794792T patent/ES3056133T3/es active Active
- 2017-09-28 NZ NZ752820A patent/NZ752820A/en unknown
- 2017-09-28 JP JP2019516149A patent/JP7265264B2/ja active Active
- 2017-09-28 BR BR112019006081-2A patent/BR112019006081B1/pt active IP Right Grant
- 2017-09-28 WO PCT/IL2017/051099 patent/WO2018061009A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020502040A5 (https=) | ||
| KR102569534B1 (ko) | 식물 공급원으로부터 칸나비노이드의 선택적 추출 방법 | |
| KR102448642B1 (ko) | 칸나비노이드의 희석 제형 및 이의 제조 방법 | |
| JP2019532940A5 (https=) | ||
| US20220088099A1 (en) | Method for extraction of an agent from a plant source | |
| JP4829963B2 (ja) | リグナン類化合物含有ｏ／ｗ／ｏ型エマルション及びそれを含有する組成物 | |
| WO2020236798A1 (en) | Nanoemulsion compositions comprising biologically active ingredients | |
| CN103347990B (zh) | 至少一种植物油精炼工业的副产物用于获得纯化的植物油总不皂化物的用途 | |
| CN101301282A (zh) | 虾青素自乳化软胶囊制剂及其制备方法 | |
| JP2014166165A (ja) | 加熱調理用油脂組成物及び該加熱調理用油脂組成物の製造方法 | |
| AU2016308080A1 (en) | Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof | |
| US20190240148A1 (en) | Lubricant composition and method for preparing the composition | |
| US20200121748A1 (en) | Cannabis formulation and method of preparation | |
| WO2014001729A2 (fr) | Compositions pour application topique comprenant un extrait naturel de plante | |
| CN103271159B (zh) | 一种液态乳品复合型增稠剂及其制备方法 | |
| JP2019523264A (ja) | クルクミンベースの薬学的組成物およびそれを製造するための方法 | |
| JP2006160644A (ja) | カプサイシン含有外用剤 | |
| CA3020613A1 (en) | Cannabis formulation and method of preparation | |
| BR102019002950B1 (pt) | Composições farmacêuticas no tratamento de afecções dermatológicas apartir do óleo vegetal de coco ariri (syagrus cocoides mart.) | |
| BR102012008718A2 (pt) | Processo de obtenção de produto funcional à base de óleo de arroz | |
| RU2017118802A (ru) | Жидкая композиция, содержащая источник железа в неионной форме, и способы применения |